Steriles Formulation Development For Commercial Success

Partner with Patheon, part of Thermo Fisher Scientific, to take your discoveries to the proof of concept milestone with speed and efficiency while laying a firm foundation for commercial success. Our formulation experts have helped clients receive more NDA approvals than any other CDMO – with 26 sterile injectable NDAs between 2006 and 2017. By offering a broad range of analytical, formulation and dosage form technologies and solutions, we can tailor a lean, fully integrated drug formulation program precisely suited to your molecule and business. This will accelerate your project to first-in-human studies and beyond.

Patheon’s CDMO experts have been developing sterile product formulations for more than 20 years, and with well over 100 years of combined formulation development experience, we’ve seen a great many formulations. Our experience and broad capabilities have helped our partners overcome many formulation challenges in areas including

  • Small and large molecules, liquid and lyophilized formulations
  • Lyophilization cycle optimization
  • Temperature and shear-sensitive compounds
  • Poorly soluble compounds
  • Highly potent compounds
  • Container closure system selection

 

Contact us to discuss your project.